U.S. Trends: Synthetic Opioid Production Remains Strong

in #health9 years ago (edited)

DEA established quotas for production of Oxycodone, a semi-synthetic opioid, have nearly quadrupled since the start of the millennium. Oxycodone is a potent painkiller derived from the Persian Poppy, with a high potential for addiction.

2009 was the height of the "Pill Mill" epidemic in South Florida, yet by 2013, nationwide production quotas for Oxycodone had increased 98%. Between 2012 and 2013 alone, production quotas showed a huge jump of 46%. During the roughly same period (2009-2013), the U.S. population increased by only 3%, from about 306 to 316 million. Since 2013, productions quotas have declined somewhat, but still remain 79% above the 2009 level.

DEA Established Oxycodone Production Quotas (for sale, grams)

YearProduction Quota (g)Percent +/-
2016139,150,000- 1.6%
2015141,375,000- 5.4%
2014149,375,000- 2.9%
2013153,750,000+ 46.2%
2012105,200,000+ 7.3%
201198,000,000- 7.2%
2010105,500,000+ 36%
200977,560,000+ 53.6%
200550,490,000+ 40.8%
200035,850,000NA

Sources:
Federal Register - 2000 Quotas
Federal Register - 2005 Quotas
Federal Register - 2009 Quotas
Federal Register - 2010 Quotas
Federal Register - 2011 Quotas
Federal Register - 2012 Quotas
Federal Register - 2013 Quotas
Federal Register - 2014 Quotas
Federal Register - 2015 Quotas
Federal Register - 2016 Quotas
Wikipedia
rxlist
U.S. Census